Simplify Logo

Full-Time

Associate Scientist II

Analytical Development, Raw Materials

Posted on 6/27/2024

Vaxcyte

Vaxcyte

201-500 employees

Develops broad-spectrum bacterial infection vaccines

Hardware
Biotechnology

Compensation Overview

$105k - $114kAnnually

+ Equity

Mid

San Carlos, CA, USA

Category
Lab & Research
Life Sciences
Physical Sciences
Required Skills
Data Analysis
Requirements
  • BS in Chemistry, Analytical Chemistry preferred, Organic / Biochemistry considered, with 2-6 years of relevant industry experience or MS with 1-4 years.
  • Experience in chemical and biological assays such as colorimetric/ fluorometric microplate assays, HPLC, CE, UV-Vis, ELISA and LC-MS.
  • Understanding of basic principles of analytical method development/ validation/ qualification concepts.
  • Attention to detail and excellent skills in record keeping/documentation.
  • Strong interpersonal skills and ability to communicate effectively both verbally and in written formats.
  • This position is a lab-based role and requires onsite presence.
Responsibilities
  • Assist in analytical method development of new assays.
  • Perform analytical testing, data analysis and present in team meetings.
  • Maintain thorough and accurate records of laboratory work.
  • Support daily lab operations, sample inventory and sample shipment.
  • Author analytical documents including but not limited to test method, protocols, and reports.

Vaxcyte is centered on creating advanced vaccines such as VAX-24, a sophisticated 24-valent pneumococcal conjugate vaccine, by utilizing cutting-edge chemistry and the XpressCF™ cell-free protein synthesis platform. The company prioritizes developing high-fidelity, broad-spectrum vaccines to combat bacterial infections, continuously expanding its product pipeline with innovations like VAX-31 for various bacterial threats.

Company Stage

IPO

Total Funding

$2.3B

Headquarters

Foster City, California

Founded

2013

Growth & Insights
Headcount

6 month growth

25%

1 year growth

50%

2 year growth

120%
INACTIVE